These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 35061902)

  • 21. Enhanced detection of malignant lymphoma in cerebrospinal fluid by multiparameter flow cytometry.
    Finn WG; Peterson LC; James C; Goolsby CL
    Am J Clin Pathol; 1998 Sep; 110(3):341-6. PubMed ID: 9728609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Approaches to overcome flow cytometry limitations in the analysis of cells from veterinary relevant species.
    Hunka J; Riley JT; Debes GF
    BMC Vet Res; 2020 Mar; 16(1):83. PubMed ID: 32143631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. One-Tube Multicolor Flow Cytometry Assay (OTMA) for Comprehensive Immunophenotyping of Peripheral Blood.
    Donaubauer AJ; Rühle PF; Becker I; Fietkau R; Gaipl US; Frey B
    Methods Mol Biol; 2019; 1904():189-212. PubMed ID: 30539471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune Cell Phenotyping Using Flow Cytometry.
    Pockley AG; Foulds GA; Oughton JA; Kerkvliet NI; Multhoff G
    Curr Protoc Toxicol; 2015 Nov; 66():18.8.1-18.8.34. PubMed ID: 26523471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of endogenous and antibody-conjugated alkaline phosphatase with ELF-97 phosphate in multicolor flow cytometry applications.
    Telford W; Cox W; Singer V
    Cytometry; 2001 Feb; 43(2):117-25. PubMed ID: 11169576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Time-Delayed Integration-Spectral Flow Cytometer (TDI-SFC) for Low-Abundance-Cell Immunophenotyping.
    Hu W; Soper SA; Jackson JM
    Anal Chem; 2019 Apr; 91(7):4656-4664. PubMed ID: 30817129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Flow cytometric analysis of lymphomas: current status and usefulness.
    Kaleem Z
    Arch Pathol Lab Med; 2006 Dec; 130(12):1850-8. PubMed ID: 17149963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunophenotypic characterization of T-cell prolymphocytic leukemia.
    Chen X; Cherian S
    Am J Clin Pathol; 2013 Nov; 140(5):727-35. PubMed ID: 24124154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monitoring of minimal residual disease in acute leukemia by multiparametric flow cytometry.
    Kusenda J; Fajtova M; Kovarikova A
    Neoplasma; 2014; 61(2):119-27. PubMed ID: 24299307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiparameter interpretative reporting in diagnostic laboratory hematology.
    Diamond LW; Mishka VG; Seal AH; Nguyen DT
    Int J Biomed Comput; 1994; 37(3):211-24. PubMed ID: 7705904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiparameter flow cytometry quantification of bone marrow plasma cells at diagnosis provides more prognostic information than morphological assessment in myeloma patients.
    Paiva B; Vidriales MB; Pérez JJ; Mateo G; Montalbán MA; Mateos MV; Bladé J; Lahuerta JJ; Orfao A; San Miguel JF; ;
    Haematologica; 2009 Nov; 94(11):1599-602. PubMed ID: 19880781
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A multidimensional classification approach for the automated analysis of flow cytometry data.
    Pedreira CE; Costa ES; Arroyo ME; Almeida J; Orfao A
    IEEE Trans Biomed Eng; 2008 Mar; 55(3):1155-62. PubMed ID: 18334408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunophenotyping of Tissue Samples Using Multicolor Flow Cytometry.
    Sykora MM; Reschke M
    Methods Mol Biol; 2019; 1953():253-268. PubMed ID: 30912027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 2006 Bethesda International Consensus recommendations on the flow cytometric immunophenotypic analysis of hematolymphoid neoplasia: medical indications.
    Davis BH; Holden JT; Bene MC; Borowitz MJ; Braylan RC; Cornfield D; Gorczyca W; Lee R; Maiese R; Orfao A; Wells D; Wood BL; Stetler-Stevenson M
    Cytometry B Clin Cytom; 2007; 72 Suppl 1():S5-13. PubMed ID: 17803188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Flow cytometric immunophenotyping of cerebrospinal fluid.
    Kraan J; Gratama JW; Haioun C; Orfao A; Plonquet A; Porwit A; Quijano S; Stetler-Stevenson M; Subira D; Wilson W
    Curr Protoc Cytom; 2008 Jul; Chapter 6():Unit 6.25. PubMed ID: 18770650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deep phenotyping of immune cell populations by optimized and standardized flow cytometry analyses.
    Pitoiset F; Cassard L; El Soufi K; Boselli L; Grivel J; Roux A; Klatzmann D; Chaput N; Rosenzwajg M
    Cytometry A; 2018 Aug; 93(8):793-802. PubMed ID: 30168890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunophenotyping by Mass Cytometry.
    Behbehani GK
    Methods Mol Biol; 2019; 2032():31-51. PubMed ID: 31522411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disruptive innovations in the clinical laboratory: catching the wave of precision diagnostics.
    Khatab Z; Yousef GM
    Crit Rev Clin Lab Sci; 2021 Dec; 58(8):546-562. PubMed ID: 34297653
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cellometer vision as an alternative to flow cytometry for cell cycle analysis, mitochondrial potential, and immunophenotyping.
    Chan LL; Zhong X; Qiu J; Li PY; Lin B
    Cytometry A; 2011 Jul; 79(7):507-17. PubMed ID: 21538841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Technical issues: flow cytometry and rare event analysis.
    Hedley BD; Keeney M
    Int J Lab Hematol; 2013 Jun; 35(3):344-50. PubMed ID: 23590661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.